Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development.
Zhou L, Liu T, Huang B, Luo M, Chen Z, Zhao Z, Wang J, Leung D, Yang X, Chan KW, Liu Y, Xiong L, Chen P, Wang H, Ye L, Liang H, Masters SL, Lew AM, Gong S, Bai F, Yang J, Pui-Wah Lee P, Yang W, Zhang Y, Lau YL, Geng L, Zhang Y, Cui J.
Zhou L, et al. Among authors: masters sl.
J Allergy Clin Immunol. 2021 Jan;147(1):267-279. doi: 10.1016/j.jaci.2020.09.003. Epub 2020 Sep 15.
J Allergy Clin Immunol. 2021.
PMID: 32941940
Clinical Trial.